Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1A Single Ascending Dose and Multiple Ascending Dose Double-Blind, Placebo-Controlled, Randomized Trial of Oral Inhalation PK10571 in Healthy Adult Subjects

NCT03473236 is registered in ClinicalTrials.gov with GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. as lead sponsor.

NCT NCT03473236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03473236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1A Single Ascending Dose and Multiple Ascending Dose Double-Blind, Placebo-Controlled, Randomized Trial of Oral Inhalation PK10571 in Healthy Adult Subjects
Lead sponsor
GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
Phase
Phase 1
Overall status
Completed
Start date
September 6, 2017
Completion date
December 3, 2018
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

safety issues